Cytokinetics

CYTK

0 Urmăritori

$32.48

-1.69%

-$0.56

Urmărește

14 August

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

CYTK Fair Price

$50.23

Undervalued by 22.4%

Pentru a afișa prețul corect al unei acțiuni, trebuie să fiți membru Bulios Black.

My Notes

Začít psát

Profile

Cytokinetics, Incorporated is an American biotechnology company specializing in the development of therapeutic approaches aimed at improving muscle function in patients with heart and muscle diseases. The company develops innovative drug candidates targeting the regulation of muscle proteins, which can help treat conditions such as heart failure, amyotrophic lateral sclerosis (ALS), and other muscle disorders. Cytokinetics focuses on providing new treatment options for patients for whom current therapies are insufficiently effective.

Feed

There are no posts to show right now.